Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$2.13B
Total Bought:
$809.98M
Total Sold:
$370.51M
Net Transaction:
+$439.47M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc1,638,1473,858,008+2,219,861$75.31M$283.91M13.31%+$208.61M
Arcellx Inc
COMMON STOCK
2,953,1223,658,624+705,502$105.96M$203.05M9.52%+$97.10M
argenx SEADR(ARGX)261,443422,577+161,134$128.53M$160.76M7.53%+$32.23M
Disc Medicine, Inc.(IRON)1,272,2792,385,857+1,113,578$59.77M$137.81M6.46%+$78.04M
Legend Biotech CorporationADS(LEGN)2,025,4801,894,644-130,836$136.05M$114.00M5.34%-$22.05M
Olema Pharmaceuticals, Inc.(OLMA)7,803,6007,903,600+100,000$96.37M$110.89M5.20%+$14.51M
Viridian Therapeutics, Inc.(VRDN)3,681,7474,794,488+1,112,741$56.48M$104.42M4.89%+$47.95M
Immunocore Holdings plcADS(IMCR)1,384,6861,453,883+69,197$71.87M$99.33M4.66%+$27.46M
Cerevel Therapeutics Hldng I2,532,9722,330,508-202,464$55.29M$98.81M4.63%+$43.52M
Xenon Pharmaceuticals Inc.(XENE)1,491,8352,127,400+635,565$50.96M$97.99M4.59%+$47.03M
Mirati Therapeutics Inc1,668,1161,543,116-125,000$72.66M$90.66M4.25%+$17.99M
Crinetics Pharmaceuticals In2,178,7372,312,919+134,182$64.80M$82.29M3.86%+$17.50M
Autolus Therapeutics plcADS(AUTL)14,406,78212,611,335-1,795,447$33.57M$81.22M3.81%+$47.65M
Bicycle Therapeutics PlcADS3,642,3073,707,001+64,694$73.17M$67.02M3.14%-$6.15M
Ambrx Biopharma Inc04,352,689+4,352,689$0$61.98M2.90%+$61.98M
Alpine Immune Sciences Inc2,421,7433,176,743+755,000$27.73M$60.55M2.84%+$32.82M
Ascendis Pharma A/SADR(ASND)0351,700+351,700$0$44.30M2.08%+$44.30M
Arvinas, Inc.(ARVN)0931,303+931,303$0$38.33M1.80%+$38.33M
TG Therapeutics, Inc.(TGTX)3,619,0152,171,419-1,447,596$30.25M$37.09M1.74%+$6.83M
Zai Lab LimitedADR(ZLAB)1,142,3831,091,779-50,604$27.77M$29.84M1.40%+$2.07M
Immatics N.V.SHS(IMTX)2,058,4472,136,339+77,892$23.84M$22.50M1.05%-$1.34M
Tarsus Pharmaceuticals, Inc.(TARS)01,025,000+1,025,000$0$20.76M0.97%+$20.76M
COMPASS Pathways plcADS(CMPS)1,358,7092,265,988+907,279$10.05M$19.83M0.93%+$9.77M
Kura Oncology, Inc.(KURA)1,212,8281,262,828+50,000$11.06M$18.16M0.85%+$7.10M
Caribou Biosciences, Inc.(CRBU)2,944,5132,923,851-20,662$14.07M$16.75M0.79%+$2.68M
Vor Biopharma Inc.(VOR)6,461,4676,457,293-4,174$13.70M$14.53M0.68%+$830.6K
Cargo Therapeutics Inc0333,333+333,333$0$7.72M0.36%+$7.72M
Zentalis Pharmaceuticals, Inc.(ZNTL)0400,000+400,000$0$6.06M0.28%+$6.06M
Aerovate Therapeutics Inc0143,235+143,235$0$3.24M0.15%+$3.24M
AMBRX BIOPHARMA INCSPONSORED ADS3,488,5960-3,488,596$40.12M$0—-$40.12M
COGENT BIOSCIENCES INCCOM(COGT)225,6050-225,605$2.20M$0—-$2.20M
INCYTE CORPCOM(INCY)912,4970-912,497$52.71M$0—-$52.71M
ROIVANT SCIENCES LTDSHS(ROIV)1,081,7670-1,081,767$12.64M$0—-$12.64M
SYNDAX PHARMACEUTICALS INCCOM(SNDX)2,390,0770-2,390,077$34.70M$0—-$34.70M
UNITED THERAPEUTICS CORP DELCOM(UTHR)307,3140-307,314$69.41M$0—-$69.41M
VERONA PHARMA PLCSPONSORED ADS926,4320-926,432$15.10M$0—-$15.10M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q4 2023 | TickerTrail